Evidence map›Paper›PMID 42307900›Full record

ArticleThe journal of physical chemistry letters2026

In-Situ Ligand-Induced Chirality Transfer in Emissive CdSe Nanoplatelets.

William Girten, Farwa Awan, Nikita S Dutta, Marissa Martinez, Jacob L Shelton, Margherita Taddei, Todd D Krauss, Joseph M Luther, Md Azimul Haque, Matthew C Beard

Abstract read
In one paragraph

Article in The journal of physical chemistry letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

William GirtenNational Laboratory of the Rockies, Golden, Colorado 80401, United States.
Farwa AwanDepartment of Chemistry, University of Rochester, Rochester, New York 14627, United States.
Nikita S DuttaNational Laboratory of the Rockies, Golden, Colorado 80401, United States.ORCID 0000-0003-2301-4010
Marissa MartinezNational Laboratory of the Rockies, Golden, Colorado 80401, United States.
Jacob L SheltonNational Laboratory of the Rockies, Golden, Colorado 80401, United States.
Margherita TaddeiNational Laboratory of the Rockies, Golden, Colorado 80401, United States.ORCID 0000-0003-4122-8418
Todd D KraussDepartment of Chemistry, University of Rochester, Rochester, New York 14627, United States.
Joseph M LutherNational Laboratory of the Rockies, Golden, Colorado 80401, United States.
Md Azimul HaqueNational Laboratory of the Rockies, Golden, Colorado 80401, United States.ORCID 0000-0003-3528-0674
Matthew C BeardNational Laboratory of the Rockies, Golden, Colorado 80401, United States.ORCID 0000-0002-2711-1355

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Terminating semiconductor nanocrystals with chiral organic ligands can induce chiroptical properties that combine the chiral character of the ligands with the strong and tunable optical properties of the nanocrystal. However, the synthesis of such chiral-modified nanocrystals is currently limited by solvent incompatibility between polar chiral ligands and nonpolar traditional ligands, as well as by ligand dissolution behavior that ultimately compromises nanocrystal quality and the degree to which chiroptical properties can be manipulated. In this work, we demonstrate a single-step synthesis of chiral cadmium selenide (CdSe) nanoplatelets (NPLs) that eliminates the need for postsynthetic ligand exchange in aqueous solvents, resulting in highly emissive chiral CdSe NPLs. By directly incorporating chiral aminodecanoic acid ligands during synthesis, we achieve in situ ligand binding and chirality transfer to CdSe NPLs. This approach produces CdSe NPLs with high photoluminescence quantum efficiencies of 50% and circular dichroism dissymmetry factors (

Identifiers

PMID42307900
PMCPMC13339767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.